WO2008010681A1 - A solid type microneedle and methods for preparing it - Google Patents
A solid type microneedle and methods for preparing it Download PDFInfo
- Publication number
- WO2008010681A1 WO2008010681A1 PCT/KR2007/003506 KR2007003506W WO2008010681A1 WO 2008010681 A1 WO2008010681 A1 WO 2008010681A1 KR 2007003506 W KR2007003506 W KR 2007003506W WO 2008010681 A1 WO2008010681 A1 WO 2008010681A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- microneedles
- biodegradable
- frame
- coated
- solid
- Prior art date
Links
- 239000007787 solid Substances 0.000 title claims abstract description 56
- 238000000034 method Methods 0.000 title claims abstract description 26
- 239000011345 viscous material Substances 0.000 claims description 14
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 10
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 10
- 229920000704 biodegradable plastic Polymers 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 229920002120 photoresistant polymer Polymers 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 12
- 210000000434 stratum corneum Anatomy 0.000 abstract description 4
- 239000012472 biological sample Substances 0.000 abstract description 2
- 238000001574 biopsy Methods 0.000 abstract description 2
- 238000001514 detection method Methods 0.000 abstract description 2
- 238000013271 transdermal drug delivery Methods 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 21
- 239000000463 material Substances 0.000 description 13
- 229940079593 drug Drugs 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 9
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 9
- 229960002160 maltose Drugs 0.000 description 9
- 229920000747 poly(lactic acid) Polymers 0.000 description 8
- 238000001727 in vivo Methods 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 238000012377 drug delivery Methods 0.000 description 6
- 239000005357 flat glass Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 229920002988 biodegradable polymer Polymers 0.000 description 3
- 239000004621 biodegradable polymer Substances 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- HBDJFVFTHLOSDW-DNDLZOGFSA-N (2r,3r,4r,5r)-2,3,5,6-tetrahydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanal;hydrate Chemical compound O.O=C[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HBDJFVFTHLOSDW-DNDLZOGFSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 238000001459 lithography Methods 0.000 description 2
- 229960003017 maltose monohydrate Drugs 0.000 description 2
- 230000037368 penetrate the skin Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 239000002195 soluble material Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000011358 absorbing material Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 229920001432 poly(L-lactide) Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002990 reinforced plastic Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0053—Methods for producing microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0061—Methods for using microneedles
Definitions
- the present invention relates to solid microneedles and a fabrication method thereof. Furthermore, the present invention relates to in vivo delivery of a drug or a cosmetic component through solid microneedles.
- microneedles are used in in vivo drug delivery, the detection of biological samples, and biopsy.
- Drug delivery with microneedles aims to deliver a drug through the skin rather than biological circulatory systems such as blood vessels or lymphatic vessels. Accordingly, the microneedles should not cause pain when they penetrate the skin, and should have sufficient length such that they can deliver drugs to the target site.
- the microneedles should have excellent physical hardness such that they can penetrate the stratum corneum having a thickness of 10-20 D. Since in-plane microneedles were suggested ("Silicon-processed Microneedles", Journal of microelectrochemical systems Vol.8, NoI, March 1999), various types of microneedles have been developed.
- a solid silicon microneedle array fabricated using an etching method was suggested as an out-of-plane microneedle array (US Patent Publication No. 2002138049, entitled “Microneedle devices and methods of manufacture and use thereof”).
- the solid silicon microneedle according to this method has a diameter of 50-10OD and a length of 500 D, and thus it has problems that it is impossible to realize painless skin penetration and that in vivo delivery of a drug or a cosmetic component to the target site is not reliably achieved.
- An array of transdermal microneedles was suggested by Nano-devices & systems Inc. (Japanese Patent Publication No.
- transdermal microneedles are used for drug delivery or cosmetic purposes and are not removed after their insertion into the skin.
- the microneedle array is fabricated by adding a composition, comprising a mixture of maltose and a drug, to a mold and solidifying the mixture in the mold.
- Said Japanese Patent suggests the fabrication of transdermal microneedles and the transdermal delivery of drugs through the fabricated microneedles, but the skin penetration of the microneedles involves pain.
- microneedle Due to the technical limitation in the fabrication of a mold, it is impossible to fabricate a microneedle, which has the length required for effective drug delivery, that is, a length of 1 mm or more, and, at the same time, an appropriate upper end diameter which causes no pain. For this reason, it is limited in its ability to allow a drug or a beauty component to permeate deep into the skin.
- Biodegradable polymer microneedles Fabrication, mechanics and transdermal drug delivery, Journal of Controlled Release 104 , 2005, 5166 and Polymer Microneedles for Controlled-Release Drug Delivery, Pharmaceutical Research, Vol. 23, No. 5, May 2006 1008).
- the fabrication of the mold for forming the external shape of the microneedles should come first, and the deformation and loss of the external shape occur in a process of separating the microneedles from the mold.
- the biodegradable solid microneedles are not removed from the body after their insertion into the body, they should cause minimal pain when they penetrate the skin, give less foreign body sensation after their insertion into the body, and, at the same time, have such a hardness that they be effectively delivered to the target site via the stratum corneum.
- the skin is comprised of the stratum corneum ( ⁇ 20 D), the epidermis ( ⁇ 100 D) and the dermis (100-3,000 D).
- the microneedles are preferably fabricated to have an upper end diameter of 5-40 D and an effective length of 1,000-2,00OD.
- biodegradable solid microneedles should be able to be fabricated using a drug or a cosmetic component as a raw material.
- the raw material thereof was limited to materials such as silicon, polymers, metal, glass or the like, due to the limitation on the fabrication methods thereof, and it was not easy to achieve the desired effects, because they were fabricated to have a diameter of 50-10OD at the upper end part and a length of 500D.
- microneedles which have a diameter small enough to realize painless penetration into the skin, and a length long enough to penetrate deep into the skin, and, at the same time, have sufficient hardness without any particular limitation on the raw materials thereof, as well as a fabrication method thereof.
- Another object of the present invention is to provide a method for fabricating solid microneedles.
- the present invention provides a method of using drawing lithography to fabricate biodegradable solid microneedles.
- the entire surface of a substance is first coated with a biodegradable viscous material to be formed into microneedles.
- a biodegradable viscous material to be formed into microneedles.
- the coated material is maintained at a suitable temperature, such that it is not solidified.
- the coated viscous material is solidified while it is drawn with the frame.
- the coated viscous material forms a structure which has a diameter decreasing from the substrate toward the surface contacting with the frame.
- the drawing process can be carried out by fixing the substrate and moving the frame upward or downward. Alternatively, it can also be performed by fixing the frame and moving the substrate upward or downward.
- biodegradable solid microneedles having a thin and long structure are fabricated either by increasing the drawing speed, such that a force greater than the tensile strength of the coated material is applied to the coated material, or by cutting a specific portion of the coated material using a laser beam.
- drawing temperature and drawing speed are suitably controlled depending on the properties of the coated material, for example, viscosity, and the desired structure of the biodegradable solid microneedles.
- the method for fabricating biodegradable solid microneedles comprises the steps of: i) coating the surface of a substrate with a viscous material for forming biodegradable solid microneedles; ii) bringing the surface of a frame having pillar patterns formed thereon, into contact with the surface of the coated viscous material; iii) drawing the coated viscous material using the frame, while solidifying the viscous material; and iv) cutting the drawn material at a given position thereof, thus obtaining biodegradable solid microneedles.
- the viscous material that is used to form the biodegradable solid microneedles is not specifically limited.
- various materials such as hydrogel, maltose, drugs for the treatment for skin diseases, cosmetic components, water-soluble materials and polymeric proteins, may be used to form the biodegradable solid microneedles.
- the number of the pillar patterns of the frame is not specifically limited, and a large number of pillar patterns may be used to produce a large amount of microneedles.
- the cutting of the microneedles can be performed by increasing the drawing speed or applying to the material a force greater than the tensile strength of the material, but the scope of the present invention is not limited thereto.
- the solid microneedles can be fabricated to have the desired diameter and length without any particular limitation.
- the solid microneedles can be fabricated to have an upper end diameter of 5-40D and an effective length of 500-2,00OD.
- the term "upper end" of microneedles means one end of the microneedle, at which the diameter is the minimum.
- the term "effective length" means the vertical length from the upper end of the microneedle to the position having a diameter of 50D.
- solid type microneedle means a microneedle which is formed in the solid state without hollow holes.
- biodegradable means that in vivo degradation occurs.
- Fig. 1 shows a frame and pillars patterned thereon, which are used for the drawing of microneedles.
- FIGs. 2a to 2f schematically show the process of fabricating biodegradable solid microneedles according to the present invention.
- Figs. 3a to 3c show the structure of biodegradable solid microneedles according to the present invention.
- Figs. 4a to 4c show the structure of an array of the inventive biodegradable solid microneedles, fabricated in the form of a patch.
- FIGs. 5a to 5d show a process in which an array of the inventive biodegradable solid microneedles, fabricated in the form of a patch, is applied to the skin.
- Figs. 6a to 6d show a process in which an array of the inventive biodegradable solid microneedles, fabricated in the form of a patch, is applied to the skin.
- Fig. 7 shows an example in which an array of the inventive biodegradable solid microneedles, fabricated in the form of a roller- type patch, is applied to the skin.
- Fig. 1 shows a frame 10 and 2x2 pillar patterns 20 formed thereon.
- the diameter of the resulting microneedles depends on the diameter of the pillar patterns formed on the frame, the diameter of the biodegradable solid microneedles may be made smaller than the diameter of the pillars patterned on the frame.
- the frame is preferably made of one selected from among metals and reinforced plastics, which do not show a great change in their properties upon changes in temperature and humidity, but the scope of the present invention is not limited thereto.
- Figs. 2a to 2f are views showing a process of fabricating solid microneedles.
- a parafilm, an aluminum foil or a band is first applied on a substrate 20 having excellent heat conductivity, such as glass or metal, and then a material for forming microneedles is coated on the substrate to form a film 21.
- the coated material, drawing rate and applied temperature are the main factors to decide the structure of the resulting biodegradable microneedles, and these factors may be suitably adjusted depending on the desired length and diameter.
- Fig. 3a is a side view of biodegradable solid microneedles 30 fabricated according to the method of the present invention; Fig.
- FIG. 3b is a plan view of the biodegradable solid microneedles 30; and Fig. 3c is a side view thereof, inclined at an angle of 45°.
- Figs. 4a to 4c show biodegradable solid microneedles fabricated using an in vivo absorbing material according to the present invention.
- Figs. 5a to 5d and Figs. 6a to 6d show an example where a patch 50 having the biodegradable solid microneedles 30 attached thereto is applied to the skin 40.
- Figs. 5a to 5d show that the patch 50 is removed immediately after it is used to insert the biodegradable solid microneedles 30 into the skin
- FIGS. 6a to 6d show that the patch 50 is removed after the biodegradable solid microneedles 30 inserted into the skin 40 are sufficiently absorbed into the skin 40.
- Figs. 7a to 7d show an example where the biodegradable solid microneedles 30 fabricated according to the present invention are applied to the skin 40 using a roller-type patch 50.
- SU-8 2050 photoresist (commercially purchased from Microchem) having a viscosity of 14,000 cStwas used to fabricate solid microneedles.
- SU-8 2050 was coated on a flat glass panel to a certain thickness, and it was maintained at 12O 0 C for 5 minutes to maintain its flowing properties. Then, the coated material was brought into contact with a frame having 2x2 pillar patterns formed thereon, each pillar having a diameter of 200 D (See Fig. 1). The temperature of the glass panel was slowly lowered to 90-95 0 C over about 5 minutes to solidify the coated SU-8 2050 and to increase the adhesion between the frame and the SU-8.
- the coated SU-8 2050 was drawn at the speed of 1 D/s for 60 minutes using the frame which adhered to the coated SU- 82050 (See Fig. 2). After 60 minutes of drawing, solid microneedles, each having a length of about 3,600D, were formed. Subsequently, the solid microneedles were cured for 30 minutes, and then the drawing speed was increased to 700 D/s in order to separate the microneedles from the frame, thus fabricating microneedles, each having a length of more than 2,000 D. Alternatively, the formed microneedles could be separated from the frame by cutting. As a result, microneedles, each having an upper end diameter of 5-30 D, an effective length of 2,000 D and a total length of 3,000 D, were fabricated.
- biodegradable plastic PLA Poly-L-lactide (commercially available from Sigma) was used to fabricate biodegradable solid microneedles. Specifically, PLA was dissolved in dichloromethane (purchased from Sigma) as a solvent, and then PLA solution was coated on a flat glass panel to a given thickness. A frame having 2x2 pillar patterns formed therein, each pattern having a diameter of 200 D, was brought into contact with the coated PLA solution. Due to the strong volatility of dichloromethane, the coated PLA solution was hardened, while the adhesion between the frame and the PLA solution was increased.
- dichloromethane purchased from Sigma
- the coated PLA was drawn at a speed of 25D/s for 90 seconds using the flame which adhered to the PLA solution, thus forming solid microneedles, each having a length of 2,200 D.
- the formed solid microneedles could be separated from the frame by increasing the drawing speed or cutting the microneedles.
- the separated biodegradable solid microneedles were crystallized in a vacuum oven at 17O 0 C, thus obtaining biodegradable plastic microneedles, each having an upper end diameter of 5 D, an effective length of 2,000 D and a strength of 1.5 N.
- CMC carboxymethyl cellulose
- Sigma which is a cellulose derivative
- CMC solution was coated on a flat glass panel to a given thickness and brought into contact with a frame having 2X2 pillar patterns formed thereon, each pillar having a diameter of 200 D.
- the coated CMC layer was dried to increase the adhesion between the frame and the CMC layer.
- the coated CMC was drawn at a speed of 30 D/s for 60 seconds using the frame which adhered to the CMC, thus forming solid microneedles, each having a length of 1,800 D.
- microneedles were dried and solidified for 5 minutes, and the solidified microneedles could be separated from the frame by increasing the drawing speed or cutting the microneedles.
- biodegradable cellulose microneedles each having an upper end diameter of 5 D and an effective length of 1,800 D, were fabricated.
- maltose monohydrate (purchased from Sigma), which is natural sugar, was used to fabricate biodegradable microneedles. Specifically, maltose monohydrate was melted at 14O 0 C to make a viscous maltose solution, which was then coated on a flat glass panel to a given thickness. Then, a frame having 2X2 pillar patterns formed thereon, each pillar having a diameter of 200 D, was brought in contact with the coated maltose layer. For 10 seconds after the contact process, the adhesion between the coated maltose layer and the frame was increased.
- biodegradable solid microneedles each having a diameter of 1,800 D.
- the solid microneedles were hardened for about 20 minutes, until the coated maltose reached 5O 0 C.
- the formed biodegradable solid microneedles could be separated from the frame by increasing the drawing speed or cutting the microneedles.
- biodegradable maltose microneedles each having an upper end diameter of 5 D and an effective length of 1,800 D, were fabricated.
- microneedles having a structure which could not be achieved by the prior art.
- the solid microneedles having a diameter of less than 50 D and a length of at least 1 mm, fabricated according to the present invention, will be useful for the in vivo delivery of not only drugs or beauty components, but also polymer materials or water-soluble materials, which were difficult to deliver in vivo in the prior art.
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008525953A JP2009501066A (en) | 2006-07-21 | 2007-07-20 | Solid microneedle and manufacturing method thereof |
US11/972,315 US20080108959A1 (en) | 2006-07-21 | 2008-01-10 | Solid type microneedle and methods for preparing it |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060068513A KR100793615B1 (en) | 2006-07-21 | 2006-07-21 | A biodegradable solid type microneedle and methods for preparing it |
KR10-2006-0068513 | 2006-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008010681A1 true WO2008010681A1 (en) | 2008-01-24 |
Family
ID=38956978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2007/003506 WO2008010681A1 (en) | 2006-07-21 | 2007-07-20 | A solid type microneedle and methods for preparing it |
Country Status (5)
Country | Link |
---|---|
US (2) | US20080108959A1 (en) |
JP (1) | JP2009501066A (en) |
KR (1) | KR100793615B1 (en) |
CN (1) | CN101330941A (en) |
WO (1) | WO2008010681A1 (en) |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010069270A (en) * | 2008-09-17 | 2010-04-02 | Yoshiichi Tobinaga | Device for administration of functional medicine and method and apparatus for manufacturing the same |
WO2010071918A1 (en) * | 2008-12-22 | 2010-07-01 | The University Of Queensland | Patch production |
CN102238938A (en) * | 2008-10-02 | 2011-11-09 | Nurim-Mwellness株式会社 | Method of manufacturing solid microstructure and solid microstructure manufactured based on same |
CN102238943A (en) * | 2008-10-01 | 2011-11-09 | Nurim-Mwellness株式会社 | Solid microstructure that enables multiple controlled release and method of manufacturing same |
JP2012500104A (en) * | 2008-08-21 | 2012-01-05 | ナインポイント メディカル, インコーポレイテッド | Devices and methods for drug evaluation and topical treatment |
US8366677B2 (en) | 2007-08-06 | 2013-02-05 | Transderm, Inc. | Microneedle arrays formed from polymer films |
US8883015B2 (en) | 2008-02-07 | 2014-11-11 | The University Of Queensland | Patch production |
US9220678B2 (en) | 2007-12-24 | 2015-12-29 | The University Of Queensland | Coating method |
US9387000B2 (en) | 2008-05-23 | 2016-07-12 | The University Of Queensland | Analyte detection using a needle projection patch |
US9572969B2 (en) | 2004-01-30 | 2017-02-21 | The University Of Queensland | Delivery device |
US9943673B2 (en) | 2010-07-14 | 2018-04-17 | Vaxxas Pty Limited | Patch applying apparatus |
US10183155B2 (en) | 2011-12-30 | 2019-01-22 | Kibur Medical, Inc. | Implantable devices and methods for evaluation of active agents |
US10390702B2 (en) | 2011-12-30 | 2019-08-27 | Kibur Medical, Inc. | Implantable devices and methods for the evaluation of active agents |
US10589077B2 (en) | 2014-12-05 | 2020-03-17 | Hisamitsu Pharmaceutical Co., Inc. | Microneedle device system |
US10603477B2 (en) | 2014-03-28 | 2020-03-31 | Allergan, Inc. | Dissolvable microneedles for skin treatment |
US11065428B2 (en) | 2017-02-17 | 2021-07-20 | Allergan, Inc. | Microneedle array with active ingredient |
US11103259B2 (en) | 2015-09-18 | 2021-08-31 | Vaxxas Pty Limited | Microprojection arrays with microprojections having large surface area profiles |
US11147954B2 (en) | 2015-02-02 | 2021-10-19 | Vaxxas Pty Limited | Microprojection array applicator and method |
US11175128B2 (en) | 2017-06-13 | 2021-11-16 | Vaxxas Pty Limited | Quality control of substrate coatings |
US11179553B2 (en) | 2011-10-12 | 2021-11-23 | Vaxxas Pty Limited | Delivery device |
US11254126B2 (en) | 2017-03-31 | 2022-02-22 | Vaxxas Pty Limited | Device and method for coating surfaces |
US11452853B2 (en) | 2015-12-24 | 2022-09-27 | Guangzhou Micnano Biotech Co., Ltd | Microneedle chip and manufacturing method thereof |
US11464957B2 (en) | 2017-08-04 | 2022-10-11 | Vaxxas Pty Limited | Compact high mechanical energy storage and low trigger force actuator for the delivery of microprojection array patches (MAP) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100938631B1 (en) | 2008-06-18 | 2010-01-22 | 주식회사 누리엠웰니스 | Process for Preparing Solid Microstructures |
US8827971B2 (en) | 2011-04-29 | 2014-09-09 | Seventh Sense Biosystems, Inc. | Delivering and/or receiving fluids |
WO2010101620A2 (en) * | 2009-03-02 | 2010-09-10 | Seventh Sense Biosystems, Inc. | Systems and methods for creating and using suction blisters or other pooled regions of fluid within the skin |
WO2012018486A2 (en) | 2010-07-26 | 2012-02-09 | Seventh Sense Biosystems, Inc. | Rapid delivery and/or receiving of fluids |
KR101030752B1 (en) | 2009-04-09 | 2011-04-26 | 한국생명공학연구원 | A Micro Needle Unit Having Controlling Function of Fluid Delivery |
KR101136739B1 (en) * | 2009-06-15 | 2012-04-19 | 주식회사 라파스 | Multi-functional Hybrid Microstructure and Process for Preparing the Same |
EP2338557A1 (en) | 2009-12-23 | 2011-06-29 | Debiotech S.A. | Soluble microneedle |
KR101254240B1 (en) | 2010-12-17 | 2013-04-12 | 주식회사 라파스 | Process for preparing microstructures |
US8545741B2 (en) | 2010-04-01 | 2013-10-01 | Nurim Wellness Co. Ltd. | Method of manufacturing microstructure |
CN101829395B (en) * | 2010-05-20 | 2012-08-22 | 上海交通大学 | Method for preparing solid micro-needle array in cutting way |
US20120041338A1 (en) * | 2010-08-13 | 2012-02-16 | Seventh Sense Biosystems, Inc. | Clinical and/or consumer techniques and devices |
WO2012021801A2 (en) | 2010-08-13 | 2012-02-16 | Seventh Sense Biosystems, Inc. | Systems and techniques for monitoring subjects |
WO2012083155A2 (en) * | 2010-12-16 | 2012-06-21 | Ams Research Corporation | Micro-needle bladder balloon |
CA2833175A1 (en) | 2011-04-29 | 2012-11-01 | Seventh Sense Biosystems, Inc. | Devices and methods for collection and/or manipulation of blood spots or other bodily fluids |
WO2012149155A1 (en) | 2011-04-29 | 2012-11-01 | Seventh Sense Biosystems, Inc. | Systems and methods for collecting fluid from a subject |
KR101314091B1 (en) * | 2011-07-26 | 2013-10-04 | 연세대학교 산학협력단 | Electro-microneedle assembly for cutaneous gene transfer in-situ and process for preparing the same |
JP6198373B2 (en) * | 2012-05-02 | 2017-09-20 | コスメディ製薬株式会社 | Micro needle |
EP2859910B1 (en) * | 2012-06-12 | 2020-03-25 | Hisamitsu Pharmaceutical Co., Inc. | Microneedle sheet |
CN105492064B (en) | 2013-06-17 | 2019-08-02 | 诸必克株式会社 | Painless and injection microstructure body without diaphragm |
KR20160052590A (en) * | 2013-09-06 | 2016-05-12 | 히사미쓰 세이야꾸 가부시키가이샤 | Micro-needle sheet |
KR101585197B1 (en) | 2014-04-10 | 2016-01-14 | 재단법인대구경북과학기술원 | Nano-Micro probe and manufacturing method of the same |
CN113908424A (en) * | 2014-04-24 | 2022-01-11 | 佐治亚科技研究公司 | Microneedle and method for producing same |
CA2945502C (en) | 2014-04-30 | 2018-01-02 | Kimberly-Clark Worldwide, Inc. | Draped microneedle array |
WO2015178730A1 (en) * | 2014-05-22 | 2015-11-26 | 연세대학교 산학협력단 | Preparation of microstructure by ccdp method |
US10292734B1 (en) * | 2014-10-24 | 2019-05-21 | Verily Life Sciences Llc | Micro-structures with magnetic removal capability and optionally clear optical path |
KR101692314B1 (en) * | 2015-03-27 | 2017-01-03 | 주식회사 주빅 | Dissolution system of lipophilic drugs into biodegradable polymer: Smart Polymer System |
KR102560153B1 (en) | 2015-04-17 | 2023-07-26 | 주식회사 엘지생활건강 | Soluble micro-needle patch for skin volume augmentation |
KR102560152B1 (en) | 2015-04-29 | 2023-07-26 | 주식회사 엘지생활건강 | Microneedle for accelerating percutaneous absorption |
KR102451112B1 (en) | 2015-04-29 | 2022-10-05 | 주식회사 엘지생활건강 | Soluble microneedle patch for glutathione delivery |
CN104921961B (en) * | 2015-05-25 | 2017-11-17 | 成都凤磐生物科技有限公司 | A kind of degradable biological microneedle patch of multiple-effect reparation |
KR102203635B1 (en) | 2015-06-10 | 2021-01-15 | 주식회사 엘지생활건강 | Fast Soluble Microneedle patch |
KR102594170B1 (en) | 2015-06-10 | 2023-10-25 | 주식회사 엘지생활건강 | Soluble microneedle patch for delivery of hydroquinone |
KR101629007B1 (en) | 2015-07-16 | 2016-06-13 | (주)비엔에스메디븐스 | A microniddle base film hanving optimal contcat angle |
CA3007753C (en) | 2015-12-28 | 2021-07-06 | Endoderma Co., Ltd. | Microstructure for transdermal absorption and method for manufacturing same |
KR101747963B1 (en) * | 2015-12-29 | 2017-06-27 | 주식회사 라파스 | A method for separating microstructure of microstructure patch |
KR101719319B1 (en) | 2016-04-05 | 2017-03-23 | 주식회사 엘지생활건강 | Micro Needle structure for efficient skin-piercing |
CN109420245A (en) * | 2017-08-30 | 2019-03-05 | 优微(珠海)生物科技有限公司 | The manufacturing method of soluble micropin |
CN108379095A (en) * | 2018-05-24 | 2018-08-10 | 优微(珠海)生物科技有限公司 | A kind of solubility microneedle patch and preparation method thereof |
KR20200001855A (en) | 2018-06-28 | 2020-01-07 | 주식회사 에스엔비아 | Microneedle Instrument For Chemical solution |
CN110693855B (en) * | 2019-10-10 | 2021-01-26 | 武汉大学 | Preparation method and application of 3D printing microneedle patch |
US20210162682A1 (en) * | 2019-12-03 | 2021-06-03 | Transderm, Inc. | Manufacture of microstructures |
KR102363524B1 (en) | 2020-10-21 | 2022-02-16 | 인제대학교 산학협력단 | Mold for microneedle manufacturing and manufacturing method thereof |
KR102635701B1 (en) | 2021-05-10 | 2024-02-08 | 인제대학교 산학협력단 | Microneedle with drug storage space and manufacturing method thereof |
CA3226577A1 (en) | 2021-07-07 | 2023-01-12 | The Regents Of The University Of California | Wearable, non-intrusive microneedle sensor |
KR102367746B1 (en) | 2021-07-27 | 2022-02-25 | 주식회사 동우글로발 | Method of manufacturing micro needle transdermal drug patch and ultrasonic delivery device thereof |
DE102021121148A1 (en) | 2021-08-13 | 2023-02-16 | EcoEnterprises GmbH | Microneedle array patch and method and device for a microneedle array patch |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6334856B1 (en) * | 1998-06-10 | 2002-01-01 | Georgia Tech Research Corporation | Microneedle devices and methods of manufacture and use thereof |
WO2003024508A2 (en) * | 2001-09-21 | 2003-03-27 | Biovalve Technologies, Inc. | Gas pressure actuated microneedle arrays, and systems and methods relating to same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU767122B2 (en) * | 1998-06-10 | 2003-10-30 | Georgia Tech Research Corporation | Microneedle devices and methods of manufacture and use thereof |
US6256533B1 (en) | 1999-06-09 | 2001-07-03 | The Procter & Gamble Company | Apparatus and method for using an intracutaneous microneedle array |
WO2002064193A2 (en) | 2000-12-14 | 2002-08-22 | Georgia Tech Research Corporation | Microneedle devices and production thereof |
JP3696513B2 (en) * | 2001-02-19 | 2005-09-21 | 住友精密工業株式会社 | Manufacturing method of needle-shaped body |
JP2005021678A (en) * | 2003-06-10 | 2005-01-27 | Medorekkusu:Kk | Pad base for percutaneous admistration and its manufacturing method |
JP4414774B2 (en) * | 2004-01-16 | 2010-02-10 | 大日本印刷株式会社 | Silicon needle manufacturing method |
JP5882556B2 (en) * | 2004-12-28 | 2016-03-09 | ナブテスコ株式会社 | Skin needle, skin needle manufacturing apparatus, and skin needle manufacturing method |
-
2006
- 2006-07-21 KR KR1020060068513A patent/KR100793615B1/en active IP Right Grant
-
2007
- 2007-07-20 JP JP2008525953A patent/JP2009501066A/en active Pending
- 2007-07-20 WO PCT/KR2007/003506 patent/WO2008010681A1/en active Application Filing
- 2007-07-20 CN CNA2007800007047A patent/CN101330941A/en active Pending
-
2008
- 2008-01-10 US US11/972,315 patent/US20080108959A1/en not_active Abandoned
-
2009
- 2009-02-18 US US12/388,509 patent/US20090163881A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6334856B1 (en) * | 1998-06-10 | 2002-01-01 | Georgia Tech Research Corporation | Microneedle devices and methods of manufacture and use thereof |
WO2003024508A2 (en) * | 2001-09-21 | 2003-03-27 | Biovalve Technologies, Inc. | Gas pressure actuated microneedle arrays, and systems and methods relating to same |
Non-Patent Citations (3)
Title |
---|
ITO K. ET AL.: "Feasibility of microneedles for percutaneous absorption of insulin", EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 29, no. 1, 3 June 2006 (2006-06-03), pages 82 - 88, XP025137171, DOI: doi:10.1016/j.ejps.2006.05.011 * |
MIYANO T. ET AL.: "Sugar Micro Needles as Transdermic Drug Delivery System", BIOMEDICAL MICRODEVICES, vol. 7, no. 3, September 2005 (2005-09-01), pages 185 - 188, XP019205102, DOI: doi:10.1007/s10544-005-3024-7 * |
PARK J.-H. ET AL.: "Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery", PROCEEDINGS OF THE 26TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE EMBS. SAN FRANCISCO, CA, USA: IEEE, September 2004 (2004-09-01), pages 2654 - 2657 * |
Cited By (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11207086B2 (en) | 2004-01-30 | 2021-12-28 | Vaxxas Pty Limited | Method of delivering material or stimulus to a biological subject |
US10751072B2 (en) | 2004-01-30 | 2020-08-25 | Vaxxas Pty Limited | Delivery device |
US9888932B2 (en) | 2004-01-30 | 2018-02-13 | Vaxxas Pty Limited | Method of delivering material or stimulus to a biological subject |
US9572969B2 (en) | 2004-01-30 | 2017-02-21 | The University Of Queensland | Delivery device |
US10377062B2 (en) | 2007-08-06 | 2019-08-13 | Transderm, Inc. | Microneedle arrays formed from polymer films |
US8366677B2 (en) | 2007-08-06 | 2013-02-05 | Transderm, Inc. | Microneedle arrays formed from polymer films |
US10022322B2 (en) | 2007-12-24 | 2018-07-17 | Vaxxas Pty Limited | Coating method |
US9220678B2 (en) | 2007-12-24 | 2015-12-29 | The University Of Queensland | Coating method |
US8883015B2 (en) | 2008-02-07 | 2014-11-11 | The University Of Queensland | Patch production |
US9283365B2 (en) | 2008-02-07 | 2016-03-15 | The University Of Queensland | Patch production |
US9387000B2 (en) | 2008-05-23 | 2016-07-12 | The University Of Queensland | Analyte detection using a needle projection patch |
US10080876B2 (en) | 2008-08-21 | 2018-09-25 | Kibur Medical, Inc. | Device and method for drug evaluation and local treatment |
JP2012500104A (en) * | 2008-08-21 | 2012-01-05 | ナインポイント メディカル, インコーポレイテッド | Devices and methods for drug evaluation and topical treatment |
JP2010069270A (en) * | 2008-09-17 | 2010-04-02 | Yoshiichi Tobinaga | Device for administration of functional medicine and method and apparatus for manufacturing the same |
CN102238943A (en) * | 2008-10-01 | 2011-11-09 | Nurim-Mwellness株式会社 | Solid microstructure that enables multiple controlled release and method of manufacturing same |
CN102238938A (en) * | 2008-10-02 | 2011-11-09 | Nurim-Mwellness株式会社 | Method of manufacturing solid microstructure and solid microstructure manufactured based on same |
JP2012504034A (en) * | 2008-10-02 | 2012-02-16 | ヌリ−エム ウェルネス カンパニー リミテッド | Manufacturing method of solid microstructure by air blowing and solid microstructure manufactured therefrom |
US8734697B2 (en) | 2008-12-22 | 2014-05-27 | The University Of Queensland | Patch production |
WO2010071918A1 (en) * | 2008-12-22 | 2010-07-01 | The University Of Queensland | Patch production |
US9943673B2 (en) | 2010-07-14 | 2018-04-17 | Vaxxas Pty Limited | Patch applying apparatus |
US11179553B2 (en) | 2011-10-12 | 2021-11-23 | Vaxxas Pty Limited | Delivery device |
US10183155B2 (en) | 2011-12-30 | 2019-01-22 | Kibur Medical, Inc. | Implantable devices and methods for evaluation of active agents |
US10390702B2 (en) | 2011-12-30 | 2019-08-27 | Kibur Medical, Inc. | Implantable devices and methods for the evaluation of active agents |
US10987503B2 (en) | 2014-03-28 | 2021-04-27 | Allergan, Inc. | Dissolvable microneedles for skin treatment |
US10603477B2 (en) | 2014-03-28 | 2020-03-31 | Allergan, Inc. | Dissolvable microneedles for skin treatment |
US10589077B2 (en) | 2014-12-05 | 2020-03-17 | Hisamitsu Pharmaceutical Co., Inc. | Microneedle device system |
US11147954B2 (en) | 2015-02-02 | 2021-10-19 | Vaxxas Pty Limited | Microprojection array applicator and method |
US11103259B2 (en) | 2015-09-18 | 2021-08-31 | Vaxxas Pty Limited | Microprojection arrays with microprojections having large surface area profiles |
US11653939B2 (en) | 2015-09-18 | 2023-05-23 | Vaxxas Pty Limited | Microprojection arrays with microprojections having large surface area profiles |
US11452853B2 (en) | 2015-12-24 | 2022-09-27 | Guangzhou Micnano Biotech Co., Ltd | Microneedle chip and manufacturing method thereof |
US11065428B2 (en) | 2017-02-17 | 2021-07-20 | Allergan, Inc. | Microneedle array with active ingredient |
US11254126B2 (en) | 2017-03-31 | 2022-02-22 | Vaxxas Pty Limited | Device and method for coating surfaces |
US11175128B2 (en) | 2017-06-13 | 2021-11-16 | Vaxxas Pty Limited | Quality control of substrate coatings |
US11828584B2 (en) | 2017-06-13 | 2023-11-28 | Vaxxas Pty Limited | Quality control of substrate coatings |
US11464957B2 (en) | 2017-08-04 | 2022-10-11 | Vaxxas Pty Limited | Compact high mechanical energy storage and low trigger force actuator for the delivery of microprojection array patches (MAP) |
Also Published As
Publication number | Publication date |
---|---|
US20090163881A1 (en) | 2009-06-25 |
JP2009501066A (en) | 2009-01-15 |
KR100793615B1 (en) | 2008-01-10 |
CN101330941A (en) | 2008-12-24 |
US20080108959A1 (en) | 2008-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20090163881A1 (en) | Solid type microneedle and methods for preparing it | |
Lim et al. | Microneedles: A versatile strategy for transdermal delivery of biological molecules | |
KR101254240B1 (en) | Process for preparing microstructures | |
Park et al. | A microneedle roller for transdermal drug delivery | |
US8236368B2 (en) | Method for preparing a hollow microneedle | |
EP2563452B1 (en) | Composite microneedle array including nanostructures thereon | |
KR100938631B1 (en) | Process for Preparing Solid Microstructures | |
WO2011105508A1 (en) | Micro-needle device and preparation method | |
EP3220997A1 (en) | Micro-needle sheet for reducing wrinkles and method of forming | |
Nayak et al. | Potential of biodegradable microneedles as a transdermal delivery vehicle for lidocaine | |
Sharma | Microneedles: an approach in transdermal drug delivery: a Review | |
WO2009094394A1 (en) | Microneedle devices and methods of drug delivery or fluid withdrawal | |
Parhi | Review of microneedle based transdermal drug delivery systems | |
CN106853271B (en) | Method for producing microstructure | |
Cheng et al. | Recent progress of micro-needle formulations: Fabrication strategies and delivery applications | |
KR101716447B1 (en) | Method for manufacturing microneedles using vibration and gravity | |
KR20160024354A (en) | Methods for Preparing Microstructures Using Centrifugal Force and Microstructures Prepared by the Same | |
KR101698846B1 (en) | Method and apparatus for manufacturing micro needle, micro needle and computer readable recording medium | |
KR102127123B1 (en) | Manufacturing method for micro-structure | |
Korkmaz et al. | Dissolvable and Coated Microneedle Arrays: Design, Fabrication, Materials and Administration Methods | |
Dugad et al. | The Microneedle Drug Delivery System and some Recent Obstacles in its Implementation | |
Anis et al. | Microneedle systems for enhanced transdermal drug delivery | |
JP2009078071A (en) | Needle body device | |
Patel Brijesh et al. | Micro needles: A Novel Trend for Transdermal Delivery technology | |
EP2563454A2 (en) | Injection molded microneedle array and method for forming the microneedle array |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780000704.7 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008525953 Country of ref document: JP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07793212 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07793212 Country of ref document: EP Kind code of ref document: A1 |